JP7427486B2 - foam skin cleanser - Google Patents
foam skin cleanser Download PDFInfo
- Publication number
- JP7427486B2 JP7427486B2 JP2020051163A JP2020051163A JP7427486B2 JP 7427486 B2 JP7427486 B2 JP 7427486B2 JP 2020051163 A JP2020051163 A JP 2020051163A JP 2020051163 A JP2020051163 A JP 2020051163A JP 7427486 B2 JP7427486 B2 JP 7427486B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- mass
- content
- foam
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006260 foam Substances 0.000 title claims description 102
- -1 polyoxyethylene glycerin Polymers 0.000 claims description 55
- 239000011550 stock solution Substances 0.000 claims description 46
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 37
- 239000000194 fatty acid Substances 0.000 claims description 37
- 229930195729 fatty acid Natural products 0.000 claims description 37
- 239000002734 clay mineral Substances 0.000 claims description 27
- 239000003599 detergent Substances 0.000 claims description 25
- 239000003380 propellant Substances 0.000 claims description 25
- 239000000443 aerosol Substances 0.000 claims description 24
- 150000004665 fatty acids Chemical class 0.000 claims description 13
- 150000004676 glycans Chemical class 0.000 claims description 12
- 229920001282 polysaccharide Polymers 0.000 claims description 12
- 239000005017 polysaccharide Substances 0.000 claims description 12
- 239000002736 nonionic surfactant Substances 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- 150000005846 sugar alcohols Polymers 0.000 claims description 6
- 239000002562 thickening agent Substances 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 4
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 229960000541 cetyl alcohol Drugs 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 2
- 229960000735 docosanol Drugs 0.000 claims description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 229940043348 myristyl alcohol Drugs 0.000 claims description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 2
- 229940055577 oleyl alcohol Drugs 0.000 claims description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims description 2
- CAYHVMBQBLYQMT-UHFFFAOYSA-N 2-decyltetradecan-1-ol Chemical compound CCCCCCCCCCCCC(CO)CCCCCCCCCC CAYHVMBQBLYQMT-UHFFFAOYSA-N 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000007789 gas Substances 0.000 description 23
- 239000003915 liquefied petroleum gas Substances 0.000 description 20
- 238000011156 evaluation Methods 0.000 description 11
- 238000005187 foaming Methods 0.000 description 11
- 238000003860 storage Methods 0.000 description 11
- 239000002202 Polyethylene glycol Substances 0.000 description 10
- 239000011777 magnesium Substances 0.000 description 10
- 229920001223 polyethylene glycol Polymers 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 229910052749 magnesium Inorganic materials 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 150000004760 silicates Chemical class 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 239000008406 cosmetic ingredient Substances 0.000 description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 4
- AOWCOHYBGYRYGE-UHFFFAOYSA-N 1-[2,3-bis(2-oxopropoxy)propoxy]propan-2-one Chemical compound CC(=O)COCC(OCC(C)=O)COCC(C)=O AOWCOHYBGYRYGE-UHFFFAOYSA-N 0.000 description 4
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 4
- DJXPNUIRGNRCPQ-UHFFFAOYSA-N 2-[2,3-bis[2-(16-methylheptadecanoyloxy)ethoxy]propoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCC(COCCOC(=O)CCCCCCCCCCCCCCC(C)C)OCCOC(=O)CCCCCCCCCCCCCCC(C)C DJXPNUIRGNRCPQ-UHFFFAOYSA-N 0.000 description 4
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 4
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 229910052618 mica group Inorganic materials 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 235000010493 xanthan gum Nutrition 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052898 antigorite Inorganic materials 0.000 description 3
- 229910052619 chlorite group Inorganic materials 0.000 description 3
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical group OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 3
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229910001651 emery Inorganic materials 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical group O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 3
- 239000000391 magnesium silicate Substances 0.000 description 3
- 229910052919 magnesium silicate Inorganic materials 0.000 description 3
- 235000019792 magnesium silicate Nutrition 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 229910052903 pyrophyllite Inorganic materials 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- AZJYLVAUMGUUBL-UHFFFAOYSA-A u1qj22mc8e Chemical compound [F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O=[Si]=O.O=[Si]=O.O=[Si]=O.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 AZJYLVAUMGUUBL-UHFFFAOYSA-A 0.000 description 3
- 229910052902 vermiculite Inorganic materials 0.000 description 3
- 239000010455 vermiculite Substances 0.000 description 3
- 235000019354 vermiculite Nutrition 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000004147 Sorbitan trioleate Substances 0.000 description 2
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 2
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 229940056318 ceteth-20 Drugs 0.000 description 2
- 229910052617 clay minerals group Inorganic materials 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229940074045 glyceryl distearate Drugs 0.000 description 2
- 229940068939 glyceryl monolaurate Drugs 0.000 description 2
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052627 muscovite Inorganic materials 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229910000269 smectite group Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000019337 sorbitan trioleate Nutrition 0.000 description 2
- 229960000391 sorbitan trioleate Drugs 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- PAFJZWHXMSQJKV-UQZRNVAESA-N (3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol;octadecanoic acid Chemical compound OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O PAFJZWHXMSQJKV-UQZRNVAESA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
- ZXNAIPHYBVMMPY-KTKRTIGZSA-N 1-erucoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCC(O)CO ZXNAIPHYBVMMPY-KTKRTIGZSA-N 0.000 description 1
- QHZLMUACJMDIAE-SFHVURJKSA-N 1-hexadecanoyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO QHZLMUACJMDIAE-SFHVURJKSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- PSQFOYNNWBCJMY-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCCOCCO PSQFOYNNWBCJMY-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- ZVTDEEBSWIQAFJ-KHPPLWFESA-N 2-hydroxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)O ZVTDEEBSWIQAFJ-KHPPLWFESA-N 0.000 description 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- LKUNXBRZDFMZOK-GFCCVEGCSA-N Capric acid monoglyceride Natural products CCCCCCCCCC(=O)OC[C@H](O)CO LKUNXBRZDFMZOK-GFCCVEGCSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000871495 Heeria argentea Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007019 Oxalis corniculata Species 0.000 description 1
- 235000016499 Oxalis corniculata Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- QHZLMUACJMDIAE-UHFFFAOYSA-N Palmitic acid monoglyceride Natural products CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 1
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 101000611641 Rattus norvegicus Protein phosphatase 1 regulatory subunit 15A Proteins 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- BKZCZANSHGDPSH-KTKRTIGZSA-N [3-(2,3-dihydroxypropoxy)-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)CO BKZCZANSHGDPSH-KTKRTIGZSA-N 0.000 description 1
- OWRMXHRUFYLLQP-UHFFFAOYSA-N [3-[2,3-bis(16-methylheptadecanoyloxy)propoxy]-2-hydroxypropyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C OWRMXHRUFYLLQP-UHFFFAOYSA-N 0.000 description 1
- OOHTWBUKWQKKEE-UHFFFAOYSA-N [6-(diethylamino)-6-hydroxy-7-oxo-7-phenylheptyl] benzoate Chemical compound C=1C=CC=CC=1C(=O)C(O)(N(CC)CC)CCCCCOC(=O)C1=CC=CC=C1 OOHTWBUKWQKKEE-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- XQGDCUULTKHHEM-UHFFFAOYSA-N butane-1,3-diol Chemical compound CC(O)CCO.CC(O)CCO XQGDCUULTKHHEM-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- VNSBYDPZHCQWNB-UHFFFAOYSA-N calcium;aluminum;dioxido(oxo)silane;sodium;hydrate Chemical compound O.[Na].[Al].[Ca+2].[O-][Si]([O-])=O VNSBYDPZHCQWNB-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229910001596 celadonite Inorganic materials 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 229910001649 dickite Inorganic materials 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 229940104869 fluorosilicate Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 229910052631 glauconite Inorganic materials 0.000 description 1
- 229940087068 glyceryl caprylate Drugs 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- 229940081618 glyceryl monobehenate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 229910052900 illite Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940025902 konjac mannan Drugs 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- VGIBGUSAECPPNB-UHFFFAOYSA-L nonaaluminum;magnesium;tripotassium;1,3-dioxido-2,4,5-trioxa-1,3-disilabicyclo[1.1.1]pentane;iron(2+);oxygen(2-);fluoride;hydroxide Chemical compound [OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[F-].[Mg+2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[K+].[K+].[K+].[Fe+2].O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2 VGIBGUSAECPPNB-UHFFFAOYSA-L 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940023750 peg-60 glyceryl isostearate Drugs 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229940056099 polyglyceryl-4 oleate Drugs 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010988 polyoxyethylene sorbitan tristearate Nutrition 0.000 description 1
- 239000001816 polyoxyethylene sorbitan tristearate Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- LKUNXBRZDFMZOK-UHFFFAOYSA-N rac-1-monodecanoylglycerol Chemical compound CCCCCCCCCC(=O)OCC(O)CO LKUNXBRZDFMZOK-UHFFFAOYSA-N 0.000 description 1
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 229910052604 silicate mineral Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 1
- 229940104870 sodium magnesium fluorosilicate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 229940100515 sorbitan Drugs 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Description
本発明は、フォーム状皮膚洗浄料に関する。 The present invention relates to foam skin cleansers.
従来、洗顔料やハンドソープ等の皮膚洗浄料の中でも、使用時に簡便に泡立てることができるものとして、エアゾールタイプのフォーム状皮膚洗浄料が知られている(例えば、特許文献1~3)。これらのフォーム状皮膚洗浄料は、細かな泡が高密度に形成された、濃密でクリーミーな泡質を得ることがきる。 Conventionally, among skin cleansing agents such as facial cleansers and hand soaps, aerosol type foam skin cleansing agents are known as those that can be easily foamed during use (for example, Patent Documents 1 to 3). These foam skin cleansers can provide a dense and creamy foam with fine bubbles formed at a high density.
これらのエアゾールタイプのフォーム状皮膚洗浄料は、原液と噴射剤としての液化ガスとがエアゾール容器に充填された形態である。それゆえ、使用前にエアゾール容器を振ることによって原液と液化ガスとを乳化させた後に、フォーム状皮膚洗浄料を吐出させる必要がある。 These aerosol type foam skin cleansers are in the form of an aerosol container filled with a stock solution and a liquefied gas as a propellant. Therefore, it is necessary to emulsify the stock solution and liquefied gas by shaking the aerosol container before use, and then discharge the foam skin cleanser.
特許文献4には、使用前にエアゾール容器を振らずに使えるフォーム状皮膚洗浄料が提案されている。 Patent Document 4 proposes a foam skin cleanser that can be used without shaking the aerosol container before use.
また、特許文献5に記載の技術では、高級アルコールや脂肪酸を使用してフォーム状皮膚洗浄料を増粘させることで、原液とガスとの分離を抑制する取組も成されている。 Furthermore, in the technique described in Patent Document 5, efforts have been made to increase the viscosity of the foamed skin cleansing agent using higher alcohols and fatty acids, thereby suppressing the separation between the stock solution and the gas.
特許文献4に開示されたフォーム状皮膚洗浄料は、液化ガスの配合量を減らし、炭酸ガスの量を増やした組成とすることによって、使用前にエアゾール容器を振らずに使えるものとなっている。しかし、特許文献4に開示されたフォーム状皮膚洗浄料は、泡質に課題がある。 The foam skin cleansing agent disclosed in Patent Document 4 has a composition in which the amount of liquefied gas is reduced and the amount of carbon dioxide gas is increased, so that it can be used without shaking the aerosol container before use. . However, the foam skin cleanser disclosed in Patent Document 4 has a problem with foam quality.
また、特許文献5に開示されたフォーム状皮膚洗浄料は、低温での原液の増粘により、(a)噴射が弱くなる、(b)発泡性が低下する、といった課題がある。 Further, the foam skin cleansing agent disclosed in Patent Document 5 has problems such as (a) weaker spraying and (b) lower foaming properties due to thickening of the stock solution at low temperatures.
本発明は、低温での安定性に優れ、低温環境で保管後も、吐出前に振ることなく、泡質に優れた泡を吐出できるフォーム状皮膚洗浄料を実現することを目的とする。 An object of the present invention is to realize a foam skin cleansing agent that has excellent stability at low temperatures and can discharge foam with excellent foam quality without shaking before discharging even after being stored in a low-temperature environment.
本発明者らは、上記課題を解決するために鋭意検討した結果、皮膚洗浄剤組成物に加えて、特定の界面活性剤を原液に所定量配合したフォーム状皮膚洗浄料が、低温での安定性に優れ、低温環境で保管後も、吐出前に振ることなく、泡質に優れた泡を吐出できるという新規知見を見出し、本発明を完成するに至った。すなわち、本発明は以下の構成を含む。 As a result of intensive studies to solve the above problems, the present inventors found that a skin cleansing foam containing a predetermined amount of a specific surfactant in a stock solution in addition to a skin cleansing composition is stable at low temperatures. The present inventors have discovered a new finding that foam with excellent foam quality can be discharged without shaking before discharge even after being stored in a low-temperature environment, leading to the completion of the present invention. That is, the present invention includes the following configuration.
〔1〕原液と、液化ガスを含む噴射剤とがエアゾール容器に充填されたフォーム状皮膚洗浄料であって、前記原液が下記成分Aを含有し、
成分Aの含有量が0.3~10.0質量%である、フォーム状皮膚洗浄料;
成分A:HLBが4~10であるノニオン界面活性剤。
[1] A foam skin cleansing agent in which a stock solution and a propellant containing a liquefied gas are filled in an aerosol container, the stock solution containing the following component A,
A foam skin cleansing agent containing 0.3 to 10.0% by mass of component A;
Component A: A nonionic surfactant with an HLB of 4 to 10.
〔2〕上記原液が下記成分BおよびCをさらに含み、成分Bの含有量が0.05~1.5質量%であり、成分Cの含有量が0.03~0.4質量%である、〔1〕のフォーム状皮膚洗浄料;
成分B:粘土鉱物
成分C:多糖類および/またはノニオン性セルロース系増粘剤。
[2] The stock solution further contains the following components B and C, the content of component B is 0.05 to 1.5% by mass, and the content of component C is 0.03 to 0.4% by mass. , the foam skin cleanser of [1];
Component B: Clay mineral Component C: Polysaccharide and/or nonionic cellulose thickener.
〔3〕上記原液が下記成分D~Hをさらに含み、前記原液/前記噴射剤の比率が83/17~97/3である、〔1〕または〔2〕のフォーム状皮膚洗浄料;
成分D:高級脂肪酸および/またはその塩
成分E:HLBが11~17であるノニオン界面活性剤
成分F:水
成分G:多価アルコール
成分H:高級アルコール。
[3] The foam skin cleanser of [1] or [2], wherein the stock solution further contains the following components D to H, and the ratio of the stock solution/the propellant is from 83/17 to 97/3;
Component D: Higher fatty acid and/or its salt Component E: Nonionic surfactant whose HLB is 11 to 17 Component F: Water Component G: Polyhydric alcohol Component H: Higher alcohol.
〔4〕上記成分Dの含有量が、0.3~5.0質量%であり、上記成分Eの含有量が、1.0~10.0質量%であり、上記成分Gの含有量が、5.0~30.0質量%であり、上記成分Hの含有量が、0.05~1.0質量%である、〔3〕のフォーム状皮膚洗浄料。 [4] The content of the component D is 0.3 to 5.0% by mass, the content of the component E is 1.0 to 10.0% by mass, and the content of the component G is , 5.0 to 30.0% by mass, and the content of the component H is 0.05 to 1.0% by mass, [3].
本発明によれば、低温での安定性に優れ、低温環境で保管後も、吐出前に振ることなく、泡質に優れた泡を吐出することができる。 According to the present invention, the foam has excellent stability at low temperatures, and even after storage in a low-temperature environment, foam with excellent foam quality can be discharged without shaking before discharge.
以下、本発明の実施の形態の一例について詳細に説明するが、本発明は、これらに限定されない。本発明は、以下に説明する各構成に限定されるものではなく、請求の範囲に示した範囲で種々の変更が可能である。また、異なる実施形態または実施例にそれぞれ開示された技術的手段を適宜組み合わせて得られる実施形態または実施例についても、本発明の技術的範囲に含まれる。さらに、各実施形態にそれぞれ開示された技術的手段を組み合わせることにより、新しい技術的特徴を形成することができる。なお、本明細書中に記載された学術文献および特許文献の全てが、本明細書中において参考文献として援用される。 Hereinafter, an example of an embodiment of the present invention will be described in detail, but the present invention is not limited thereto. The present invention is not limited to each configuration described below, and various changes can be made within the scope of the claims. Further, embodiments or examples obtained by appropriately combining technical means disclosed in different embodiments or examples are also included in the technical scope of the present invention. Furthermore, new technical features can be formed by combining the technical means disclosed in each embodiment. Note that all academic literature and patent literature described in this specification are incorporated as references in this specification.
本明細書において特記しない限り、数値範囲を表す「X~Y」は、「X以上Y以下」を意図する。また、本明細書において特記しない限り、成分の含有量を表す質量%は、フォーム状皮膚洗浄料の原液全体の質量を100質量%とした値である。 In this specification, unless otherwise specified, the numerical range "X to Y" is intended to be "more than or equal to X and less than or equal to Y." In addition, unless otherwise specified in this specification, mass % representing the content of a component is a value based on the mass of the entire stock solution of the foam skin cleansing agent as 100 mass %.
〔1.フォーム状皮膚洗浄料〕
本発明に係るフォーム状皮膚洗浄料は、原液と、液化ガスを含む噴射剤とがエアゾール容器に充填されたフォーム状皮膚洗浄料であって、前記原液が下記成分Aを含有し、成分Aの含有量が0.3~10.0質量%である;
成分A:HLBが4~10のノニオン界面活性剤。
[1. Foam skin cleanser〕
The foam skin cleansing material according to the present invention is a foam skin cleansing material in which an aerosol container is filled with a stock solution and a propellant containing a liquefied gas, the stock solution containing the following component A, and a propellant containing a liquefied gas. The content is 0.3 to 10.0% by mass;
Component A: Nonionic surfactant with HLB of 4 to 10.
本発明に係るフォーム状皮膚洗浄料は、低温環境(例えば5℃)で保管後も、吐出前に振ることなく、泡質に優れた泡を吐出することができる。吐出前にフォーム状皮膚洗浄料を振ることなく泡質に優れた泡を吐出する上で、低温環境での保管は、常温環境での保管よりも厳しい条件となる。それゆえ、本発明に係るフォーム状皮膚洗浄料は、低温環境だけでなく常温環境で保管しても、吐出前に振ることなく、泡質に優れた泡を吐出することができることはいうまでもない。 Even after being stored in a low-temperature environment (for example, 5° C.), the foam skin cleanser according to the present invention can discharge foam with excellent foam quality without shaking before discharge. In order to discharge foam with excellent foam quality without shaking the foamed skin cleansing agent before dispensing, storage in a low temperature environment is a more severe condition than storage in a room temperature environment. Therefore, it goes without saying that the foam skin cleanser of the present invention can discharge foam with excellent foam quality without shaking before dispensing, even when stored not only in a low-temperature environment but also in a room-temperature environment. do not have.
また、上記原液は、上記成分Aに加えて、以下成分BおよびCをさらに含んでいてもよい;
成分B:粘土鉱物
成分C:多糖類および/またはノニオン性セルロース系増粘剤。
Further, the stock solution may further contain the following components B and C in addition to the component A;
Component B: Clay mineral Component C: Polysaccharide and/or nonionic cellulose thickener.
また、上記原液は、洗浄剤組成物として、以下成分D~Hをさらに含んでいてもよい。 Further, the stock solution may further contain the following components D to H as a cleaning composition.
成分D:高級脂肪酸および/またはその塩
成分E:HLBが11~17であるノニオン界面活性剤
成分F:水
成分G:多価アルコール
成分H:高級アルコール。
Component D: Higher fatty acid and/or its salt Component E: Nonionic surfactant whose HLB is 11 to 17 Component F: Water Component G: Polyhydric alcohol Component H: Higher alcohol.
また、本発明のフォーム状皮膚洗浄料は、上述した成分以外に、他の成分を含んでいてもよい。 Further, the foamed skin cleanser of the present invention may contain other components in addition to the above-mentioned components.
また、上記原液/上記噴射剤の比率は、83/17~98/2、好ましくは88/12~97/3である。起泡性、および低温での吐出安定性の観点から、上記比率は83/17以上であればよい。また、フォーム状皮膚洗浄料の吐出状態および泡質の観点から、上記比率は97/3以下であればよい。 Further, the ratio of the above-mentioned stock solution/the above-mentioned propellant is 83/17 to 98/2, preferably 88/12 to 97/3. From the viewpoint of foaming properties and discharge stability at low temperatures, the ratio may be 83/17 or more. Further, from the viewpoint of the discharge state and foam quality of the foam skin cleanser, the above ratio may be 97/3 or less.
また、成分A、成分B、成分C、成分D、成分E、成分F、成分G、成分H、および、その他の成分はそれぞれ、1種のみが用いられてもよく、2種以上が用いられてもよい。 In addition, only one type of component A, component B, component C, component D, component E, component F, component G, component H, and other components may be used, or two or more types may be used. It's okay.
以下、本発明に係るフォーム状皮膚洗浄料に用いられる各成分の詳細を説明する。 The details of each component used in the foam skin cleanser according to the present invention will be explained below.
〔1-1.原液〕
〔成分A〕
本発明に係るフォーム状皮膚洗浄料は、成分Aとして、HLBが4~10であるノニオン界面活性剤を含む。この成分Aは、本発明に係るフォーム状皮膚洗浄料において、原液と液化ガス(例えば液化石油ガス:LPG)との相溶性を向上させる役割を有する。
[1-1. Stock solution]
[Component A]
The foam skin cleanser according to the present invention contains, as component A, a nonionic surfactant having an HLB of 4 to 10. This component A has the role of improving the compatibility between the stock solution and the liquefied gas (for example, liquefied petroleum gas: LPG) in the foam skin cleanser according to the present invention.
成分AのHLBは、4~10、好ましくは7~9である。フォーム状皮膚洗浄料の泡質の観点から、当該HLBは、4以上であればよい。また、原液と液化ガスとの相溶性の観点から、当該HLBは、10以下であればよい。 The HLB of component A is 4-10, preferably 7-9. From the viewpoint of foam quality of the foam skin cleanser, the HLB may be 4 or more. Further, from the viewpoint of compatibility between the stock solution and the liquefied gas, the HLB may be 10 or less.
上記HLBが4~10であるノニオン界面活性剤としては、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンアルキルエーテルなどが挙げられる。酸化エチレンの付加モル数は、特に限定されないが、安定性を高める観点から、2~100であることが好ましく、より好ましくは、4~90である。 Examples of the nonionic surfactant having an HLB of 4 to 10 include polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, sorbitan fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl ether, and the like. The number of moles of ethylene oxide added is not particularly limited, but from the viewpoint of improving stability, it is preferably 2 to 100, more preferably 4 to 90.
上記成分Aの具体例としては、例えば、オレイン酸ポリグリセリル-4、ステアリン酸ポリグリセリル-4、トリイソステアリン酸PEG-10グリセリル、トリイソステアリン酸PEG-20グリセリル、イソステアリン酸PEG-3グリセリル、イソステアリン酸PEG-6グリセリル、トリオレイン酸PEG-10グリセリル、トリオレイン酸PEG-20グリセリル、ラウリン酸ソルビタン、PEG-5水添ヒマシ油、PEG-10水添ヒマシ油、セテス-5、セテス-10などが挙げられる。好適な成分Aは、1種を単独で用いてもよく、2種以上を適宜組み合わせて用いてもよい。 Specific examples of the above component A include polyglyceryl-4 oleate, polyglyceryl-4 stearate, PEG-10 glyceryl triisostearate, PEG-20 glyceryl triisostearate, PEG-3 glyceryl isostearate, and PEG-3 isostearate. 6 glyceryl, PEG-10 glyceryl trioleate, PEG-20 glyceryl trioleate, sorbitan laurate, PEG-5 hydrogenated castor oil, PEG-10 hydrogenated castor oil, ceteth-5, ceteth-10, etc. . One type of suitable component A may be used alone, or two or more types may be used in an appropriate combination.
また、成分Aの含有量は、0.3~10.0質量%、好ましくは0.4~5.0質量%である。原液と液化ガスとの相溶性の観点から、上記含有量は、0.3質量%以上であればよい。また、フォーム状皮膚洗浄料の泡質の観点から、上記含有量は、10.0質量%以下であればよい。 Further, the content of component A is 0.3 to 10.0% by mass, preferably 0.4 to 5.0% by mass. From the viewpoint of compatibility between the stock solution and the liquefied gas, the content may be 0.3% by mass or more. Further, from the viewpoint of the foam quality of the foam skin cleanser, the content may be 10.0% by mass or less.
〔成分B〕
本発明に係るフォーム状皮膚洗浄料は、成分Bとして、粘土鉱物を含むことが好ましい。この成分Bは、本発明に係るフォーム状皮膚洗浄料において、原液に対してチキソトロピー性を付与し、液化ガス(例えば液化石油ガス:LPG)と原液との分離を抑制する役割を有する。成分Bは、1種類のみを用いてもよいし、2種類以上を併せて用いてもよい。
[Component B]
The foam skin cleanser according to the present invention preferably contains clay mineral as component B. In the foam skin cleanser according to the present invention, component B has the role of imparting thixotropy to the stock solution and suppressing separation of the stock solution from liquefied gas (for example, liquefied petroleum gas: LPG). Only one type of component B may be used, or two or more types may be used in combination.
上記粘土鉱物は、天然の粘土鉱物であってもよく、天然の粘土鉱物を精製したものであってもよく、合成された粘土鉱物であってもよい。上記成分Aとしては、特に限定されないが、例えば、天然の粘土鉱物または天然の粘土鉱物を精製したものとしては、カオリン族粘土鉱物、アンティゴライト族粘土鉱物、パイロフィライト族粘土鉱物、雲母族粘土鉱物、スメクタイト族粘土鉱物、バーミキュライト族粘土鉱物、および緑泥石族粘土鉱物等が挙げられる。 The clay mineral may be a natural clay mineral, a refined natural clay mineral, or a synthesized clay mineral. The above-mentioned component A is not particularly limited, but examples of natural clay minerals or refined natural clay minerals include kaolin group clay minerals, antigorite group clay minerals, pyrophyllite group clay minerals, and mica group clay minerals. Examples include clay minerals, smectite group clay minerals, vermiculite group clay minerals, and chlorite group clay minerals.
上記カオリン族粘土鉱物としては、カオリン、ナクライト、ディッカイトおよびハロサイト等が挙げられる。上記アンティゴライト族粘土鉱物としては、アンティゴライト、アメサイトおよびクロンステダイト等が挙げられる、上記パイロフィライト族粘土鉱物としては、パイロフィライトおよびタルク(滑石)等が挙げられる。上記雲母族粘土鉱物としては、イライト、海緑石、セラドナイト、セリサイト、マイカ(雲母)、白雲母、クロム白雲母および黒雲母等が挙げられる。上記スメクタイト族粘土鉱物としては、ベンナイト、モンモリロナイト、スメクタイト、バイデライト、ノントナイト、サポナイトおよびヘクトライト等が挙げられる。上記バーミキュライト族粘土鉱物としては、バーミキュライト等が挙げられる。上記緑泥石族粘土鉱物としては、緑泥石(クロライト)等が挙げられる。 Examples of the kaolin group clay minerals include kaolin, nacrite, dickite, and hallosite. Examples of the antigorite group clay minerals include antigorite, amethite, cronstedite, and the like; examples of the pyrophyllite group clay minerals include pyrophyllite, talc, and the like. Examples of the mica group clay minerals include illite, glauconite, celadonite, sericite, mica (mica), muscovite, chromium muscovite, and biotite. Examples of the smectite group clay minerals include bennite, montmorillonite, smectite, beidellite, nontonite, saponite, and hectorite. Examples of the vermiculite group clay mineral include vermiculite and the like. Examples of the chlorite group clay minerals include chlorite and the like.
また、合成された粘土鉱物としては、合成ケイ酸塩および合成ケイ酸塩の誘導体が挙げられる。上記合成ケイ酸塩及び合成ケイ酸塩の誘導体とは、天然由来のケイ酸マグネシウムやケイ酸(ナトリウム/マグネシウム)などを主成分とするケイ酸塩鉱物(少なからず不純物が含まれる)ではなく、合成によって得られるケイ酸塩及びケイ酸塩の誘導体のことを言う。 Furthermore, examples of synthesized clay minerals include synthetic silicates and derivatives of synthetic silicates. The above-mentioned synthetic silicates and synthetic silicate derivatives are not silicate minerals whose main components are naturally occurring magnesium silicate or silicic acid (sodium/magnesium) (which contain a considerable amount of impurities), Refers to silicates and silicate derivatives obtained by synthesis.
上記合成ケイ酸塩及び合成ケイ酸塩の誘導体としては、例えば、合成ケイ酸(ナトリウム/マグネシウム)(INCI名「SODIUM MAGNESIUM SILICATE」:International Cosmetic Ingredient Dictionary and Handbook,第14版,第2巻,CTFA,2012年,p.3076)、フルオロケイ酸マグネシウム(INCI名「MAGNESIUM FLUOROSILICATE」:International Cosmetic Ingredient Dictionary and Handbook,第14版,第2巻,CTFA,2012年,p.1793)、フルオロケイ酸(ナトリウム/マグネシウム)(INCI名「SODIUM MAGNESIUM FLUOROSILICATE」:International Cosmetic Ingredient Dictionary and Handbook,第14版,第2巻,CTFA,2012年,p.3076)、フルオロケイ酸(マグネシウム/カリウム)(INCI名「MAGNESIUM POTASSIUM FLUOROSILICATE」:International Cosmetic Ingredient Dictionary and Handbook,第14版,第2巻,CTFA,2012年,p.1799)、フルオロケイ酸(マグネシウム/ナトリウム)(INCI名「MAGNESIUM SODIUM FLUOROSILICATE」:International Cosmetic Ingredient Dictionary and Handbook,第14版,第2巻,CTFA,2012年,p.1800)、合成ケイ酸アルミニウム(INCI名「ALUMINUM SILICATE」:International Cosmetic Ingredient Dictionary and Handbook,第14版,第1巻,CTFA,2012年,p.156)等が挙げられる。 Examples of the synthetic silicates and derivatives of synthetic silicates include synthetic silicic acid (sodium/magnesium) (INCI name "SODIUM MAGNESIUM SILICATE": International Cosmetic Ingredient Dictionary and Handbook, 14th edition, Vol. 2) ,CTFA , 2012, p. 3076), Magnesium fluorosilicate (INCI name "MAGNESIUM FLUOROSILICATE": International Cosmetic Ingredient Dictionary and Handbook, 14th edition, Volume 2, CTF A, 2012, p. 1793), fluorosilicic acid ( Sodium/Magnesium) (INCI name "SODIUM MAGNESIUM FLUOROSILICATE": International Cosmetic Ingredient Dictionary and Handbook, 14th edition, Volume 2, CTFA, 2012, p. .3076), fluorosilicic acid (magnesium/potassium) (INCI name “ MAGNESIUM POTASSIUM FLUOROSILICATE”: International Cosmetic Ingredient Dictionary and Handbook, 14th edition, Volume 2, CTFA, 2012, p. 1799), full Orosilicic acid (magnesium/sodium) (INCI name "MAGNESIUM SODIUM FLUOROSILICATE": International Cosmetic Ingredient Dictionary and Handbook, 14th edition, Volume 2, CTFA, 2012, p. 1800), synthetic aluminum silicate (INCI name "ALUMINUM SILICATE": International Cosmetic Ingredient Dictionary) ary and Handbook, 14th edition, Volume 1, CTFA , 2012, p. 156).
上記合成ケイ酸塩および合成ケイ酸塩の誘導体の市販品としては、例えば、ロックウッド社製、商品名「ラポナイトXLG」及び商品名「ラポナイトXL21」等が挙げられる。 Commercially available products of the synthetic silicate and derivatives of the synthetic silicate include, for example, those manufactured by Rockwood Co., Ltd. under the trade name "Laponite XLG" and the trade name "Laponite XL21."
本発明において、原液と液化ガス(例えば液化石油ガス:LPG)との相溶性の観点から、上記成分Bは、フルオロケイ酸(ナトリウム/マグネシウム)、合成ケイ酸ナトリウム・マグネシウム、およびベントナイトからなる群から選ばれる少なくとも1種の粘土鉱物であることが好ましい。 In the present invention, from the viewpoint of compatibility between the stock solution and liquefied gas (for example, liquefied petroleum gas: LPG), the component B is a group consisting of fluorosilicic acid (sodium/magnesium), synthetic sodium/magnesium silicate, and bentonite. Preferably, it is at least one type of clay mineral selected from.
上記成分Bの含有量は、好ましくは0.05~1.5質量%、より好ましくは0.08~1.0質量%、さらに好ましくは0.2~0.5質量%である。液化ガス(例えば液化石油ガス:LPG)と原液との分離抑制の観点から、上記含有量は、0.05質量%以上が好ましい。また、フォーム状皮膚洗浄料の低温保管状態での原液の粘度上昇を抑制する観点から、上記含有量は、1.5質量%以下が好ましい。 The content of component B is preferably 0.05 to 1.5% by mass, more preferably 0.08 to 1.0% by mass, and even more preferably 0.2 to 0.5% by mass. From the viewpoint of suppressing separation between liquefied gas (for example, liquefied petroleum gas: LPG) and the stock solution, the content is preferably 0.05% by mass or more. Moreover, from the viewpoint of suppressing the increase in viscosity of the stock solution of the foamed skin cleansing material during low-temperature storage, the content is preferably 1.5% by mass or less.
〔成分C〕
本発明に係るフォーム状皮膚洗浄料は、成分Cとして、多糖類および/またはノニオン性セルロース系増粘剤を含むことが好ましい。この成分Cは、本発明に係るフォーム状皮膚洗浄料において、液化ガス(例えば液化石油ガス:LPG)と原液との分離を抑制する役割を有する。成分Cは、1種類のみを用いてもよいし、2種類以上を併せて用いてもよい。
[Component C]
It is preferable that the foamed skin cleanser according to the present invention contains a polysaccharide and/or a nonionic cellulose thickener as component C. This component C has the role of suppressing separation of the liquefied gas (for example, liquefied petroleum gas: LPG) and the stock solution in the foam skin cleansing material according to the present invention. Only one type of component C may be used, or two or more types may be used in combination.
上記多糖類は、具体的には、多糖類系増粘剤である。成分Cの多糖類は、特に限定されないが、ノニオン性多糖類であることが好ましい。ノニオン性多糖類は、例えば、グルコース、ガラクトース、マンノース、アラビノース、キシロースなどの単糖類の1種又は2種以上で構成されてなる多糖類である。具体的なノニオン性多糖類としては、例えば、デキストラン、プルラン、アラビノガラクタン、グァーガム、タラガム、ローカストビーンガム、コンニャクマンナン、タマリンド種子ガム、キサンタンガムなどが挙げられる。これら成分は、1種を単独で用いてもよく、2種以上を適宜組み合わせて用いることもできる。好適な多糖類としては、製剤安定性の観点から、キサンタンガムを用いることが好ましい。 Specifically, the polysaccharide is a polysaccharide thickener. The polysaccharide of component C is not particularly limited, but is preferably a nonionic polysaccharide. Nonionic polysaccharides are, for example, polysaccharides composed of one or more monosaccharides such as glucose, galactose, mannose, arabinose, and xylose. Specific examples of nonionic polysaccharides include dextran, pullulan, arabinogalactan, guar gum, tara gum, locust bean gum, konjac mannan, tamarind seed gum, and xanthan gum. These components may be used alone or in an appropriate combination of two or more. As a suitable polysaccharide, it is preferable to use xanthan gum from the viewpoint of formulation stability.
また、ノニオン性セルロース系増粘剤は、特に限定されないが、メチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロースなどが挙げられる。 In addition, nonionic cellulose-based thickeners include, but are not particularly limited to, methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, and the like.
上記成分Cの含有量は、好ましくは0.03~0.4質量%、より好ましくは0.05~0.25質量%、さらに好ましくは0.07~0.15質量%である。液化ガス(例えば液化石油ガス:LPG)と原液との分離抑制の観点から、上記含有量は、0.03質量%以上が好ましい。また、フォーム状皮膚洗浄料の低温保管状態での原液の粘度上昇を抑制する観点から、上記含有量は、0.4質量%以下が好ましい。 The content of component C is preferably 0.03 to 0.4% by mass, more preferably 0.05 to 0.25% by mass, and even more preferably 0.07 to 0.15% by mass. From the viewpoint of suppressing separation between the liquefied gas (for example, liquefied petroleum gas: LPG) and the stock solution, the content is preferably 0.03% by mass or more. Moreover, from the viewpoint of suppressing the increase in viscosity of the stock solution of the foamed skin cleansing material during low-temperature storage, the content is preferably 0.4% by mass or less.
〔成分D〕
本発明に係るフォーム状皮膚洗浄料は、成分Dとして、高級脂肪酸および/またはその塩、すなわち、即ち、高級脂肪酸および高級脂肪酸塩のうちのいずれか一方または両方を含むことが好ましい。この成分Dは、本発明に係るフォーム状皮膚洗浄料において、洗浄成分として作用しフォーム状皮膚洗浄料の洗浄力を高めるとともに、フォーム状皮膚洗浄料の起泡性及び泡もちの向上に効果的である。さらに、泡密度の高い濃密な泡を形成することに効果的である。上記成分Dは、1種のみを用いてもよいし、2種以上を用いてもよい。
[Component D]
It is preferable that the foamed skin cleanser according to the present invention contains, as component D, a higher fatty acid and/or a salt thereof, that is, one or both of a higher fatty acid and a higher fatty acid salt. In the foamed skin cleansing agent according to the present invention, this component D acts as a cleaning component to enhance the cleaning power of the foamed skin cleansing agent, and is effective in improving the foaming properties and foam retention of the foamed skin cleansing agent. It is. Furthermore, it is effective in forming dense foam with high foam density. The above component D may be used alone or in combination of two or more.
上記高級脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、ベヘニン酸等の炭素数12~22の高級脂肪酸;オリーブ油、ヤシ油、パーム油、綿実油等の植物性油脂;魚油、牛脂等の動物性油脂等が挙げられる。中でも、フォーム状皮膚洗浄料の洗浄力、起泡性、泡もちの観点から、炭素数12~22の高級脂肪酸塩が好ましく、ラウリン酸、ミリスチン酸、パルミチン酸、及びステアリン酸がより好ましい。 Examples of the higher fatty acids include higher fatty acids having 12 to 22 carbon atoms such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, and behenic acid; vegetable oils and fats such as olive oil, coconut oil, palm oil, and cottonseed oil. ; Examples include animal fats and oils such as fish oil and beef tallow. Among these, higher fatty acid salts having 12 to 22 carbon atoms are preferred, and lauric acid, myristic acid, palmitic acid, and stearic acid are more preferred, from the viewpoint of detergency, foaming properties, and foam retention of the foam skin cleanser.
上記高級脂肪酸塩における塩としては、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩;モノエタノールアミン塩、ジエタノールアミン塩、トリエタノールアミン塩等のアルカノールアミン塩等が挙げられる。 Examples of the salts in the higher fatty acid salts include alkali metal salts such as sodium salts and potassium salts; alkanolamine salts such as monoethanolamine salts, diethanolamine salts, and triethanolamine salts.
上記高級脂肪酸塩は、予め塩に調製された高級脂肪酸塩が配合されていてもよいし、高級脂肪酸と塩基とが原液中で塩を形成していてもよい。 The above-mentioned higher fatty acid salt may contain a higher fatty acid salt prepared in advance as a salt, or a higher fatty acid and a base may form a salt in an undiluted solution.
上記成分Dの含有量は、高級脂肪酸の量として、好ましくは0.3~5.0質量%、より好ましくは0.5~3.0質量%である。起泡性、洗浄性の観点から、上記含有量は0.3質量%以上であればよい。また、フォーム状皮膚洗浄料の低温保管状態での原液の粘度上昇を抑制する観点から、上記含有量は5.0質量%以下であればよい。上記含有量は、原液中に含まれる全ての成分Dの含有量(高級脂肪酸として換算した場合の含有量)の合計量である。 The content of component D is preferably 0.3 to 5.0% by mass, more preferably 0.5 to 3.0% by mass as the amount of higher fatty acids. From the viewpoint of foaming properties and cleansing properties, the content may be 0.3% by mass or more. In addition, from the viewpoint of suppressing the increase in viscosity of the stock solution of the foamed skin cleansing material during low-temperature storage, the content may be 5.0% by mass or less. The above content is the total amount of all components D contained in the stock solution (content when converted into higher fatty acids).
〔成分E〕
本発明に係るフォーム状皮膚洗浄料は、成分Eとして、HLBが11~17であるノニオン界面活性剤を含むことが好ましい。この成分Eは、本発明に係るフォーム状皮膚洗浄料において、洗浄成分として作用しフォーム状皮膚洗浄料の洗浄力を高めるとともに、フォーム状皮膚洗浄料の起泡性及び泡もちの向上に効果的である。さらに、泡密度の高い濃密な泡を形成することに効果的である。上記成分Eは、1種のみを用いてもよいし、2種以上を用いてもよい。
[Component E]
The foam skin cleanser according to the present invention preferably contains a nonionic surfactant having an HLB of 11 to 17 as component E. In the foamed skin cleansing agent according to the present invention, this component E acts as a cleaning component to enhance the cleaning power of the foamed skin cleansing agent, and is effective in improving the foaming properties and foam retention of the foamed skin cleansing agent. It is. Furthermore, it is effective in forming dense foam with high foam density. The above component E may be used alone or in combination of two or more.
成分Eとしては、例えば、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル 、グリセリン脂肪酸エステルの酸化エチレン縮合物、ポリエチレングリコール脂肪酸エステル、プロピレングリコール脂肪酸エステル、ソルビタン脂肪酸エステル、ソルビタン脂 肪酸エステルの酸化エチレン縮合物、ポリオキシアルキレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンヒマシ油、ポリオキシエチレンラノリン等が挙げられる。 Component E includes, for example, glycerin fatty acid ester, polyglycerin fatty acid ester, ethylene oxide condensate of glycerin fatty acid ester, polyethylene glycol fatty acid ester, propylene glycol fatty acid ester, sorbitan fatty acid ester, ethylene oxide condensate of sorbitan fatty acid ester, Examples include polyoxyalkylene alkyl ether, polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil, polyoxyethylene lanolin, and the like.
より具体的には、例えば、モノカプリル酸グリセリル、モノカプリン酸グリセリル、モノラウリン酸グリセリル、モノミリスチン酸グリセリル、モノパルミチン酸グリセリル、モノステアリン酸グリセリル、モノイソステアリン酸グリセリル、モノベヘン酸グリセリル、モノオレイン酸グリセリル、モノエルカ酸グリセリル、セスキオレイン酸グリセリル、ジステアリン酸グリセリル、ジイソステアリン酸グリセリル、ジアラキン酸グリセリル等のグリセリン脂肪酸エステル;モノカプリル酸ジグリセリル、モノカプリル酸デカグリセリル、モノカプリン酸ヘキサグリセリル、モノラウリン酸テトラグリセリル、モノラウリン酸ヘキサグリセリル、モノラウリン酸デカグリセリル、モノラウリン酸ポリ(4~10)グリセリル、モノミリスチン酸デカグリセリル(ミリスチン酸ポリグリセリル-10)、モノステアリン酸デカグリセリル、モノイソステアリン酸デカグリセリル、モノステアリン酸ポリ(2~10)グリセリル、モノオレイン酸ジグリセリル、モノオレイン酸ヘキサグリセリル、セスキオレイン酸ジグリセリル、ジイソステアリン酸ポリ(2~10)グリセリル、ジステアリン酸ポリ(6~10)グリセリル、トリイソステアリン酸ジグリセリル、トリステアリン酸ポリ(10)グリセリル等のポリグリセリン脂肪酸エステル;モノステアリン酸ポリオキシエチレングリセリル、モノオレイン酸ポリオキシエチレングリセリル等のグリセリン脂肪酸エステルの酸化エチレン縮合物;モノオレイン酸ポリエチレングリコール、モノステアリン酸ポリエチレングリコール、モノラウリン酸ポリエチレングリコール等のポリエチレングリコール脂肪酸エステル;モノステアリン酸プロピレングリコール、モノラウリン酸プロピレングリコール、モノオレイン酸プロピレングリコール等のプロピレングリコール脂肪酸エステル;モノオレイン酸ソルビタン、モノステアリン酸ソルビタン、モノイソステアリン酸ソルビタン、モノパルミチン酸ソルビタン、モノラウリン酸ソルビタン、トリオレイン酸ソルビタン、トリステアリン酸ソルビタン、セスキステアリン酸ソルビタン、セスキオレイン酸ソルビタン、セスキイソステアリン酸ソルビタン、ヤシ油脂肪酸ソルビタン等のソルビタン脂肪酸エステル;モノラウリン酸ポリオキシエチレンソルビタン、モノパルミチン酸ポリオキシエチレンソルビタン、モノステアリン酸ポリオキシエチレンソルビタン、モノオレイン酸ポリオキシエチレンソルビタン、モノイソステアリン酸ポリオキシエチレンソルビタン、モノヤシ油脂肪酸ポリオキシエチレンソルビタン、トリステアリン酸ポリオキシエチレンソルビタン、トリオレイン酸ポリオキシエチレンソルビタン等のソルビタン脂肪酸エステルの酸化エチレン縮合物;ポリオキシエチレンラウリルエーテル、ポリオキシエチレンセチルエーテル(セテス-20)、ポリオキシエチレンステアリルエーテル、ポリオキシエチレンオレイルエーテル、ポリオキシエチレンポリオキシプロピレンラウリルエーテル、ポリオキシプロピレンセチルエーテル、ポリオキシプロピレンイソセチルエーテル、ポリオキシプロピレンステアリルエーテル、ポリオキシプロピレンオレイルエーテル等のポリオキシアルキレンアルキルエーテル等が挙げられる。 More specifically, for example, glyceryl monocaprylate, glyceryl monocaprate, glyceryl monolaurate, glyceryl monomyristate, glyceryl monopalmitate, glyceryl monostearate, glyceryl monoisostearate, glyceryl monobehenate, glyceryl monooleate. , glyceryl fatty acid esters such as glyceryl monoerucate, glyceryl sesquioleate, glyceryl distearate, glyceryl diisostearate, glyceryl dialachate; diglyceryl monocaprylate, decaglyceryl monocaprylate, hexaglyceryl monocaprate, tetraglyceryl monolaurate, Hexaglyceryl monolaurate, decaglyceryl monolaurate, poly(4-10)glyceryl monolaurate, decaglyceryl monomyristate (polyglyceryl-10 myristate), decaglyceryl monostearate, decaglyceryl monoisostearate, poly(4-10) monostearate 2-10) Glyceryl, diglyceryl monooleate, hexaglyceryl monooleate, diglyceryl sesquioleate, poly(2-10) glyceryl diisostearate, poly(6-10) glyceryl distearate, diglyceryl triisostearate, Polyglycerin fatty acid esters such as poly(10)glyceryl tristearate; ethylene oxide condensates of glycerin fatty acid esters such as polyoxyethylene glyceryl monostearate and polyoxyethylene glyceryl monooleate; polyethylene glycol monooleate, monostearic acid Polyethylene glycol fatty acid esters such as polyethylene glycol, polyethylene glycol monolaurate; Propylene glycol fatty acid esters such as propylene glycol monostearate, propylene glycol monolaurate, propylene glycol monooleate; sorbitan monooleate, sorbitan monostearate, monoisostearic acid Sorbitan fatty acid esters such as sorbitan, sorbitan monopalmitate, sorbitan monolaurate, sorbitan trioleate, sorbitan tristearate, sorbitan sesquistearate, sorbitan sesquioleate, sorbitan sesquiisostearate, and coconut fatty acid sorbitan; polyoxy monolaurate Ethylene sorbitan, polyoxyethylene sorbitan monopalmitate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan monoisostearate, monococo fatty acid polyoxyethylene sorbitan, polyoxyethylene sorbitan tristearate , ethylene oxide condensates of sorbitan fatty acid esters such as polyoxyethylene sorbitan trioleate; polyoxyethylene lauryl ether, polyoxyethylene cetyl ether (cetheth-20), polyoxyethylene stearyl ether, polyoxyethylene oleyl ether, polyoxy Examples include polyoxyalkylene alkyl ethers such as ethylene polyoxypropylene lauryl ether, polyoxypropylene cetyl ether, polyoxypropylene isocetyl ether, polyoxypropylene stearyl ether, and polyoxypropylene oleyl ether.
上記成分Eの含有量は、好ましくは1.0~10.0質量%、より好ましくは3.0~8.0質量%である。起泡性および洗浄性の観点から、上記含有量は1.0質量%以上であればよい。また、フォーム状皮膚洗浄料の洗い流し易さの観点から、上記含有量は10.0質量%以下であればよい。 The content of component E is preferably 1.0 to 10.0% by mass, more preferably 3.0 to 8.0% by mass. From the viewpoint of foaming properties and detergency, the content may be 1.0% by mass or more. Further, from the viewpoint of ease of washing off the foam skin cleanser, the content may be 10.0% by mass or less.
〔成分F〕
本発明に係るフォーム状皮膚洗浄料は、成分Fとして、水を含むことが好ましい。成分Fは、特に限定されないが、精製水が好ましい。成分Fの水の含有量は、成分F以外の成分の含有量に応じて適宜設定得るが、好ましくは65.0~85.0質量%であり、より好ましくは70.0~80.0質量%である。
[Component F]
The foam skin cleanser according to the present invention preferably contains water as component F. Component F is not particularly limited, but purified water is preferred. The content of water in component F can be appropriately set depending on the content of components other than component F, but is preferably 65.0 to 85.0% by mass, more preferably 70.0 to 80.0% by mass. %.
〔成分G〕
本発明に係るフォーム状皮膚洗浄料は、成分Gとして、多価アルコールを含むことが好ましい。成分Gの多価アルコールは、泡もちに効果的である。また、高級脂肪酸塩等の結晶の析出を抑制する効果もある。さらに、泡質を滑らかにし、クリーミーな泡とする効果もある。上記成分Gは、1種のみを用いてもよいし、2種以上を用いてもよい。
[Component G]
The foam skin cleanser according to the present invention preferably contains polyhydric alcohol as component G. Component G, polyhydric alcohol, is effective in maintaining foam. It also has the effect of suppressing the precipitation of crystals such as higher fatty acid salts. Furthermore, it has the effect of smoothing the foam and making it creamy. The above-mentioned component G may be used alone or in combination of two or more.
上記成分Gとしては、例えば、エチレングリコール、ジエチレングリコール、トリエチレングリコール、プロピレングリコール、イソプレングリコール、ジプロピレングリコール(DPG)、ポリエチレングリコール(PEG)、1,3-ブチレングリコール(1,3-ブタンジオール)、1,2-ブタンジオール、1,2-ペンタンジオール、1,2-ヘキサンジオール、1,2-オクタンジオール、1,2-デカンジオール、グリセリン(1,2,3-プロパントリオール)、ジグリセリン、ポリグリセリン、ソルビトール、マルチトール、ポリオキシエチレンメチルグルコシド、ポリオキシプロピレンメチルグルコシド等が挙げられる。 Examples of the component G include ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, isoprene glycol, dipropylene glycol (DPG), polyethylene glycol (PEG), and 1,3-butylene glycol (1,3-butanediol). , 1,2-butanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, glycerin (1,2,3-propanetriol), diglycerin , polyglycerin, sorbitol, maltitol, polyoxyethylene methyl glucoside, polyoxypropylene methyl glucoside, and the like.
上記成分Gの含有量は、適宜設定可能であるが、好ましくは5.0~30.0質量%、より好ましくは10.0~25.0質量%である。固形成分の析出抑制効果の観点から、上記含有量は、5.0質量%以上であればよい。また、フォーム状皮膚洗浄料の洗い流し易さの観点から、上記含有量は、25.0質量%以下であればよい。上記含有量は、原液中に含まれる全ての成分Gの含有量の合計量である。 The content of the component G can be set as appropriate, but is preferably 5.0 to 30.0% by mass, more preferably 10.0 to 25.0% by mass. From the viewpoint of suppressing precipitation of solid components, the content may be 5.0% by mass or more. Further, from the viewpoint of ease of washing off the foam skin cleanser, the content may be 25.0% by mass or less. The above content is the total content of all components G contained in the stock solution.
多価アルコールは、固形成分の析出抑制効果をより一層向上させ、さらに泡密度の高い濃密な泡を形成する観点から、ポリエチレングリコールを含有していることが好ましい。 The polyhydric alcohol preferably contains polyethylene glycol from the viewpoint of further improving the effect of suppressing precipitation of solid components and forming dense foam with high foam density.
上記ポリエチレングリコールの数平均分子量は、特に限定されないが、好ましくは50~10000、より好ましくは100~5000である。 The number average molecular weight of the polyethylene glycol is not particularly limited, but is preferably 50 to 10,000, more preferably 100 to 5,000.
上記ポリエチレングリコールの含有量は、泡もち、泡密度及び結晶の析出抑制効果を高める観点から、好ましくは0.1~10.0質量%、より好ましくは0.5~8.0質量%である。 The content of the polyethylene glycol is preferably 0.1 to 10.0% by mass, more preferably 0.5 to 8.0% by mass from the viewpoint of improving foam retention, foam density, and crystal precipitation suppressing effect. .
〔成分H〕
本発明に係るフォーム状皮膚洗浄料は、成分Hとして、高級アルコールを含むことが好ましい。この成分Hは、本発明に係るフォーム状皮膚洗浄料において、泡質を向上するという役割を有する。成分Hは、1種類のみを用いてもよいし、2種類以上を併せて用いてもよい。
[Component H]
The foam skin cleanser according to the present invention preferably contains higher alcohol as component H. This component H has the role of improving foam quality in the foam skin cleanser according to the present invention. Only one type of component H may be used, or two or more types may be used in combination.
成分Hの高級アルコールは、特に限定されないが、例えば、ラウリルアルコール、ミリスチルアルコール、セチルアルコール(セタノール)、ステアリルアルコール、セテアリルアルコール、イソステアリルアルコール、ヘキシルデカノール、2-オクチルドデカノール、オレイルアルコール、デシルテトラデカノール、ベヘニルアルコール等が挙げられる。 The higher alcohol of component H is not particularly limited, but includes, for example, lauryl alcohol, myristyl alcohol, cetyl alcohol (cetanol), stearyl alcohol, cetearyl alcohol, isostearyl alcohol, hexyldecanol, 2-octyldodecanol, oleyl alcohol, decyltetra Examples include decanol and behenyl alcohol.
上記成分Hの含有量は、適宜設定可能であるが、好ましくは0.05~1.0質量%、より好ましくは0.1~0.8質量%である。乳化安定性および起泡性の観点から、上記含有量は、0.05質量%以上であればよい。また、フォーム状皮膚洗浄料の低温保管状態での原液の粘度上昇を抑制する観点から、上記含有量は、1.0質量%以下であればよい。 The content of component H can be set as appropriate, but is preferably 0.05 to 1.0% by mass, more preferably 0.1 to 0.8% by mass. From the viewpoint of emulsion stability and foaming properties, the content may be 0.05% by mass or more. In addition, from the viewpoint of suppressing the increase in viscosity of the stock solution of the foamed skin cleansing material during low-temperature storage, the content may be 1.0% by mass or less.
〔その他の成分〕
上記原液は、特に限定されないが、上記成分A~H以外の成分(その他の成分)を含んでもよい。例えば、香料;シクロペンタシロキサン、ハイドロゲンジメチコン、カプリリルメチコン、メチルフェニルポリシロキサン、ジメチコン等のシリコーン油;フェノキシエタノール、オクトキシグリセリン、メチルパラベン等の防腐剤;メントール、メンチルグリセリルエーテル、カンファー、ペパーミント油等の冷感剤;グリチルリチン酸ジカリウム、グリチルリチン酸ステアリル等の抗炎症剤;シャクヤク、ボタンピ、ビワ、アロエ等の植物抽出エキス;殺菌剤;トコフェロール、ジブチルヒドロキシトルエン等の酸化防止剤;メトキシケイヒ酸オクチル、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸オクチル、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、t-ブチルメトキシジベンゾイルメタン、オクチルトリアゾン、パラメトキシケイ皮酸2-エチルヘキシルなどの紫外線吸収剤;エデト酸塩等のキレート剤;アルブチン、アスコルビン酸等の美白剤;シリカ、タルク、ナイロンパウダー等の粉体などを含んでもよい。
[Other ingredients]
The above-mentioned stock solution is not particularly limited, but may contain components other than the above-mentioned components A to H (other components). For example, fragrance; silicone oil such as cyclopentasiloxane, hydrogen dimethicone, caprylyl methicone, methylphenyl polysiloxane, dimethicone; preservatives such as phenoxyethanol, octoxyglycerin, methylparaben; menthol, menthyl glyceryl ether, camphor, peppermint oil, etc. Cooling agents; anti-inflammatory agents such as dipotassium glycyrrhizinate and stearyl glycyrrhizinate; plant extracts such as peony, botanpi, loquat, and aloe; bactericides; antioxidants such as tocopherol and dibutylhydroxytoluene; octyl methoxycinnamate, dimethoxy UV absorbers such as benzylidene dioxoimidazolidine octyl propionate, diethylaminohydroxybenzoylhexyl benzoate, t-butylmethoxydibenzoylmethane, octyl triazone, and 2-ethylhexyl paramethoxycinnamate; chelating agents such as edetate; It may also contain whitening agents such as arbutin and ascorbic acid; powders such as silica, talc, and nylon powder.
上記殺菌剤としては、例えば、イソプロピルメチルフェノール、塩化ベンザルコニウム、ヒノキチオール、トリクロサン、グリチルリチン酸ジカリウム、及びサリチル酸等が挙げられる。なかでも、イソプロピルメチルフェノール、サリチル酸がより好ましく、サリチル酸がさらに好ましい。上記殺菌剤は、1種のみを用いてもよいし、2種以上を用いてもよい。 Examples of the above-mentioned disinfectants include isopropylmethylphenol, benzalkonium chloride, hinokitiol, triclosan, dipotassium glycyrrhizinate, and salicylic acid. Among these, isopropylmethylphenol and salicylic acid are more preferred, and salicylic acid is even more preferred. The above-mentioned fungicides may be used alone or in combination of two or more.
〔1-2.噴射剤〕
本発明のフォーム状皮膚洗浄料の噴射剤は、起泡性の観点、原液と噴射剤との相溶性の観点から、液化ガスを含有する。液化ガスとしては、液化石油ガス(LPG:Liquefied Petroleum Gas)、ジメチルエーテル(DME:Dimethyl ether)、イソペンタン、フルオロカーボン等の液化ガスなどが挙げられる。液化ガスは、1種のみを用いてもよいし、2種以上を用いてもよい。なお、上記噴射剤は、液化ガスに加え、空気、窒素、炭酸ガス、亜酸化窒素等の圧縮ガスを併用してもよい。
[1-2. Propellant]
The propellant of the foam skin cleanser of the present invention contains a liquefied gas from the viewpoint of foaming properties and compatibility between the stock solution and the propellant. Examples of the liquefied gas include liquefied petroleum gas (LPG), dimethyl ether (DME), isopentane, and fluorocarbon. Only one type of liquefied gas may be used, or two or more types may be used. In addition to the liquefied gas, the propellant may be a compressed gas such as air, nitrogen, carbon dioxide, or nitrous oxide.
上記噴射剤100質量%中の、液化ガスの含有量は、好ましくは98.0質量%以上、より好ましくは99.0質量%以上、さらに好ましくは100質量%である。 The content of liquefied gas in 100% by mass of the propellant is preferably 98.0% by mass or more, more preferably 99.0% by mass or more, and even more preferably 100% by mass.
また、本発明のフォーム状皮膚洗浄料の噴射剤は、エアゾール容器の内圧の調整が容易である観点、原液と噴射剤との相溶性の観点、泡質の観点から、液化石油ガスを含有していることが好ましい。 In addition, the propellant of the foam skin cleanser of the present invention does not contain liquefied petroleum gas, from the viewpoint of easy adjustment of the internal pressure of the aerosol container, the compatibility between the stock solution and the propellant, and the foam quality. It is preferable that
上記噴射剤100質量%中の、液化石油ガスの含有量は、好ましくは50.0質量%以上、より好ましくは70.0質量%以上、さらに好ましくは90.0質量%以上、最も好ましくは99.0質量%以上である。 The content of liquefied petroleum gas in 100% by mass of the propellant is preferably 50.0% by mass or more, more preferably 70.0% by mass or more, still more preferably 90.0% by mass or more, and most preferably 99% by mass or more. .0% by mass or more.
〔2.フォーム状皮膚洗浄料の製造方法および用途〕
本発明のフォーム状皮膚洗浄料は、既知の方法により製造することができる。例えば、原液をエアゾール容器に充填し、エアゾール用バルブにより容器をクリンチした後、規定量の噴射剤をステムから容器内へ充填し、噴射ボタンを装着する、という製造方法を例示することができる。なお、エアゾール容器としては、公知慣用の容器が挙げられ、特に限定されない。
[2. Manufacturing method and use of foam skin cleanser]
The foam skin cleanser of the present invention can be manufactured by known methods. For example, a manufacturing method can be exemplified in which a stock solution is filled into an aerosol container, the container is clinched by an aerosol valve, a prescribed amount of propellant is filled into the container from the stem, and an injection button is attached. Note that the aerosol container includes well-known and commonly used containers, and is not particularly limited.
原液と噴射剤との混合比(質量比、組成物/噴射剤)は、適宜設定可能であるが、好ましくは83/17~98/2、より好ましくは88/12~97/3である。起泡性の観点、および低温での吐出安定性の観点から、上記混合比は、83/17以上であればよい。また、吐出状態および泡質の観点から、上記混合比は、98/2以下であればよい。 The mixing ratio (mass ratio, composition/propellant) of the stock solution and the propellant can be set as appropriate, but is preferably 83/17 to 98/2, more preferably 88/12 to 97/3. From the viewpoint of foaming properties and discharge stability at low temperatures, the mixing ratio may be 83/17 or more. Further, from the viewpoint of discharge state and foam quality, the above-mentioned mixing ratio may be 98/2 or less.
本発明のフォーム状皮膚洗浄料は、顔等の皮膚を洗浄するために用いられる皮膚洗浄料である。本発明のフォーム状皮膚洗浄料としては、洗顔料、ハンドソープ、ボディソープや頭皮の洗浄料等が挙げられる。本発明のフォーム状皮膚洗浄料は、洗浄後の肌のつっぱり感を抑制し、キメの細かいしっかりとした濃密な泡を形成するものであるので、特に洗顔料等、デリケートな部位の洗浄料に適している。 The foamed skin cleansing agent of the present invention is a skin cleansing agent used for cleaning the skin of the face and the like. Examples of the foamed skin cleanser of the present invention include facial cleansers, hand soaps, body soaps, and scalp cleansers. The foamed skin cleansing agent of the present invention suppresses the feeling of tightness on the skin after washing and forms a firm, dense foam with a fine texture, so it is particularly suitable for use as a cleansing agent for delicate areas such as facial cleansing agent. Are suitable.
本発明の一実施例について、以下に説明する。 An embodiment of the present invention will be described below.
〔1.実施例1~16および比較例1~6〕
表1および表2に示すように各成分を配合することにより、実施例1~16および比較例1~6の原液を調製した。そして、表1および表2に示した原液比率および噴射剤比率にて、原液と噴射剤とを配合してエアゾール容器に充填することにより、フォーム状皮膚洗浄料を得た。なお、エアゾール容器本体の材質としては、透明なガラス製のエアゾール容器と、アルミ製のエアゾール容器を用いた。
[1. Examples 1 to 16 and Comparative Examples 1 to 6]
Stock solutions of Examples 1 to 16 and Comparative Examples 1 to 6 were prepared by blending each component as shown in Tables 1 and 2. Then, the stock solution and propellant were blended at the stock solution ratio and propellant ratio shown in Tables 1 and 2, and the mixture was filled into an aerosol container to obtain a foam skin cleanser. As for the material of the aerosol container body, a transparent glass aerosol container and an aluminum aerosol container were used.
なお、噴射剤として、液化石油ガス(LPG)を使用した。そして、エアゾール容器内のガス圧が0.39MPaとなるように、液化石油ガスをエアゾール容器内へ充填した。 Note that liquefied petroleum gas (LPG) was used as the propellant. Then, liquefied petroleum gas was filled into the aerosol container so that the gas pressure within the aerosol container was 0.39 MPa.
〔2.各成分の詳細〕
表1および表2中、各成分の詳細は以下の通りである。
[2. Details of each ingredient]
In Tables 1 and 2, details of each component are as follows.
<成分A>
トリイソステアリン酸PEG-20グリセリル(HLB:8):日本エマルジョン社製、製品名「EMALEX GWIS-320」、
セテス-5(HLB:9.4):日本エマルジョン社製、製品名「EMALEX 105」、
PEG-10水添ヒマシ油(HLB:7):日本エマルジョン社製、製品名「EMALEX HC-10」、
トリオレイン酸PEG-10グリセリル(HLB:5):日本エマルジョン社製、製品名「EMALEX GWO-310」、
<成分Aに相当しないノニオン界面活性剤>
イソステアリン酸PEG-60グリセリル(HLB:16):日本エマルジョン社製、製品名「EMALEX GWIS-160」、
トリオレイン酸PEG-5グリセリル(HLB:3):日本エマルジョン社製、製品名「EMALEX GWO-305」、
PEG-30水添ヒマシ油(HLB:11):日本エマルジョン社製、製品名「EMALEX HC-30」。
<Component A>
PEG-20 glyceryl triisostearate (HLB: 8): manufactured by Nippon Emulsion Co., Ltd., product name “EMALEX GWIS-320”,
Seteth-5 (HLB: 9.4): Manufactured by Nippon Emulsion Co., Ltd., product name "EMALEX 105",
PEG-10 hydrogenated castor oil (HLB: 7): manufactured by Nippon Emulsion Co., Ltd., product name “EMALEX HC-10”,
PEG-10 glyceryl trioleate (HLB: 5): manufactured by Nippon Emulsion Co., Ltd., product name “EMALEX GWO-310”,
<Nonionic surfactant not corresponding to component A>
PEG-60 glyceryl isostearate (HLB: 16): manufactured by Nippon Emulsion Co., Ltd., product name “EMALEX GWIS-160”,
PEG-5 glyceryl trioleate (HLB: 3): manufactured by Nippon Emulsion Co., Ltd., product name "EMALEX GWO-305",
PEG-30 hydrogenated castor oil (HLB: 11): manufactured by Nippon Emulsion Co., Ltd., product name "EMALEX HC-30".
<成分B>
フルオロケイ酸(Na/Mg):Rockwood Additives Limited社製、製品名「Laponite XL21」、
ベントナイト:日本有機粘土社製、製品名「ベンゲル」。
<Component B>
Fluorosilicic acid (Na/Mg): manufactured by Rockwood Additives Limited, product name “Laponite XL21”,
Bentonite: Manufactured by Japan Organic Clay Co., Ltd., product name "Benger".
<成分C>
キサンタンガム:DSP五協フード&ケミカル社製、製品名「エコーガム T」、
ヒドロキシエチルセルロース:ダイセル化学工業社製、製品名「HECダイセル SE900」。
<Component C>
Xanthan gum: manufactured by DSP Gokyo Food & Chemical Co., product name “Echo Gum T”,
Hydroxyethyl cellulose: manufactured by Daicel Chemical Industries, Ltd., product name "HEC Daicel SE900".
<成分D>
ラウリン酸:Emery Oleochemicals社製、製品名「EDENOR C12-99 (C)」、
ミリスチン酸:Emery Oleochemicals社製、製品名「EDENOR C14-99(C)」、
パルミチン酸:Emery Oleochemicals社製、製品名「EDENOR C16-98 MY」、
トリエタノールアミン:ジャパンケムテック社製、製品名「TEA-99」。
<Component D>
Lauric acid: manufactured by Emery Oleochemicals, product name “EDENOR C12-99 (C)”,
Myristic acid: manufactured by Emery Oleochemicals, product name "EDENOR C14-99 (C)",
Palmitic acid: manufactured by Emery Oleochemicals, product name “EDENOR C16-98 MY”,
Triethanolamine: manufactured by Japan Chemtech, product name "TEA-99".
<成分E>
ミリスチン酸ポリグリセリル-10(HLB:14.9):青木油脂工業社製、製品名「グリーフ 10MM」、
セテス-20(HLB:15.5):青木油脂工業社製、製品名「ブラウノン CH-320L」。
<Component E>
Polyglyceryl myristate-10 (HLB: 14.9): manufactured by Aoki Yushi Kogyo Co., Ltd., product name “Grief 10MM”,
Ceteth-20 (HLB: 15.5): Manufactured by Aoki Yushi Kogyo Co., Ltd., product name "Brownon CH-320L".
<成分G>
濃グリセリン:阪本薬品工業社製、製品名「化粧用濃グリセリン」、
DPG:オクサリスケミカルズ社製、製品名「ジプロピレングリコールS」、
PEG-32、PEG-6:青木油脂工業社製、製品名「ブラウノン PEG-1500」。
<Component G>
Concentrated glycerin: Manufactured by Sakamoto Pharmaceutical Co., Ltd., product name: “Cosmetic Concentrated Glycerin”
DPG: Manufactured by Oxalis Chemicals, product name “dipropylene glycol S”,
PEG-32, PEG-6: Manufactured by Aoki Yushi Kogyo Co., Ltd., product name: "Brownon PEG-1500".
<成分H>
セタノール:花王社製、製品名「カルコール 6870」。
<Component H>
Setanol: Manufactured by Kao Corporation, product name "Calcol 6870".
<その他の成分>
フェノキシエタノール:四日市合成社製、製品名「フェノキシエタノール-S」。
<Other ingredients>
Phenoxyethanol: Manufactured by Yokkaichi Gosei Co., Ltd., product name "Phenoxyethanol-S".
〔3.評価〕
実施例1~16および比較例1~10のフォーム状皮膚洗浄料を低温(5℃)で8週間保管した。そして、保管後のフォーム状皮膚洗浄料に対して、以下の評価を行った。なお、評価試験直前にエアゾール容器を振らずに以下の評価を行った。
[3. evaluation〕
The foam skin cleansers of Examples 1 to 16 and Comparative Examples 1 to 10 were stored at low temperature (5° C.) for 8 weeks. The foamed skin cleanser after storage was evaluated as follows. In addition, the following evaluation was performed without shaking the aerosol container immediately before the evaluation test.
<3-1.低温での安定性>
透明のガラス製のエアゾール容器を用いて評価した。保管後のフォーム状皮膚洗浄料における内容物の分離状態を目視で観察することにより低温での安定性を評価した。
<3-1. Stability at low temperatures>
Evaluation was performed using a transparent glass aerosol container. Stability at low temperatures was evaluated by visually observing the state of separation of the contents in the foam skin cleanser after storage.
(評価基準)
◎:内容物の外観が均一な状態である場合、低温での安定性を「◎」と評価した。
○:内容物の上端と下端とで若干の相違があるが、分離していない場合、低温での安定性を「○」と評価した。
×:噴射剤の層と原液の層とが分離している場合、低温での安定性を「×」と評価した。
(Evaluation criteria)
◎: When the appearance of the contents was uniform, the stability at low temperature was evaluated as "◎".
○: There is a slight difference between the upper end and the lower end of the contents, but if they are not separated, the stability at low temperature was evaluated as "○".
×: When the propellant layer and the stock solution layer were separated, the stability at low temperature was evaluated as “x”.
<3-2.低温での粘性>
透明のガラス製のエアゾール容器を用いて評価した。保管後のフォーム状皮膚洗浄料を傾けた際の内容物の流動性を目視で観察することにより低温での粘性を評価した。
<3-2. Viscosity at low temperature>
Evaluation was performed using a transparent glass aerosol container. The viscosity at low temperatures was evaluated by visually observing the fluidity of the contents when the foamed skin cleanser was tilted after storage.
(評価基準)
◎:フォーム状皮膚洗浄料を傾けるのに合わせて内容物が流動する場合、低温での粘性を「◎」と評価した。
○:◎より粘性があるが、フォーム状皮膚洗浄料を傾けた後、5秒未満で内容物の流動が完了する場合、低温での粘性を「○」と評価した。
×:フォーム状皮膚洗浄料を傾けても流動しない場合、または、フォーム状皮膚洗浄料を傾けた後、内容物の流動が完了するまでに5秒以上要する場合、低温での粘性を「×」と評価した。
(Evaluation criteria)
◎: When the contents flow as the foamed skin cleanser is tilted, the viscosity at low temperatures was evaluated as "◎".
○: It is more viscous than ◎, but when the contents flow completely in less than 5 seconds after tilting the foam skin cleanser, the viscosity at low temperature was evaluated as "○".
×: If the foamed skin cleansing agent does not flow even when tilted, or if it takes 5 seconds or more for the contents to complete flowing after tilting the foamed skin cleansing agent, the viscosity at low temperatures is marked “×” It was evaluated as follows.
<3-3.低温での噴射状態>
アルミ製のエアゾール容器を用いて評価した。保管後のフォーム状皮膚洗浄料を、手の平に2秒間吐出させた際の吐出状態と発泡状態とを目視で観察することにより低温での噴射状態を評価した。
<3-3. Injection condition at low temperature>
Evaluation was performed using an aluminum aerosol container. The spraying state at low temperatures was evaluated by visually observing the ejection state and foaming state when the stored foamed skin cleansing agent was ejected onto the palm of the hand for 2 seconds.
(評価基準)
◎:スムーズに泡状で吐出される場合、低温での噴射状態を「◎」と評価した。
○:スムーズに吐出されるが完全に発泡するまでに3秒未満要する場合、低温での噴射状態を「○」と評価した。
×:吐出がスムーズでない場合、または、スムーズに吐出されるが完全に発泡するまでに3秒以上要する場合、低温での噴射状態を「×」と評価した。
(Evaluation criteria)
◎: When the foam is discharged smoothly, the injection condition at low temperature was evaluated as "◎".
○: When the ink was discharged smoothly but it took less than 3 seconds to completely foam, the low-temperature injection condition was evaluated as "○".
×: When the discharge is not smooth, or when the discharge is smooth but it takes 3 seconds or more to completely foam, the low-temperature injection condition was evaluated as "x".
<3-4.低温での泡質>
アルミ製のエアゾール容器を用いて評価した。保管後のフォーム状皮膚洗浄料を、手の平に2秒間吐出させた際の泡質を目視で観察することにより低温での泡質を評価した。
<3-4. Foam quality at low temperatures>
Evaluation was performed using an aluminum aerosol container. The foam quality at low temperatures was evaluated by visually observing the foam quality when the stored foam skin cleanser was discharged onto the palm of the hand for 2 seconds.
(評価基準)
◎:きめ細かい均一な泡である場合、低温での泡質を「◎」と評価した。
○:きめ細かい泡であるが、一部粗い箇所がある場合、低温での泡質を「○」と評価した。
×:粗い泡である場合、および/または消泡する場合、低温での泡質を「×」と評価した。
(Evaluation criteria)
◎: When the foam is fine and uniform, the foam quality at low temperature was evaluated as "◎".
○: Fine foam, but if there are some rough spots, the foam quality at low temperature was evaluated as "○".
×: In the case of coarse foam and/or in the case of defoaming, the foam quality at low temperature was evaluated as “x”.
〔4.試験結果〕
表1~表3から、「低温での安定性」、「低温での粘性」、「低温での噴射状態」、および「低温での泡質」の何れについても、参考例1~6、および実施例7~16のフォーム状皮膚洗浄料は、比較例1~6のフォーム状皮膚洗浄料よりも優れていることが明らかになった。したがって、参考例1~6、および実施例7~16のフォーム状皮膚洗浄料は、低温での安定性に優れ、低温環境で保管後も、吐出前に振ることなく、泡質に優れた泡を吐出することができる。
[4. Test results〕
From Tables 1 to 3, reference examples 1 to 6 and The foamed skin cleansers of Examples 7 to 16 were found to be superior to the foamed skin cleansers of Comparative Examples 1 to 6 . Therefore, the foam skin cleansers of Reference Examples 1 to 6 and Examples 7 to 16 have excellent stability at low temperatures, and even after storage in a low temperature environment, they can produce foam with excellent foam quality without shaking before dispensing. can be discharged.
〔処方例1〕
(原液)
トリイソステアリン酸PEG-20グリセリル 0.5質量%
フルオロケイ酸(Na/Mg) 0.3質量%
キサンタンガム 0.1質量%
ミリスチン酸ポリグリセリル-10 3.0質量%
セテス-20 1.5質量%
濃グリセリン 10.0質量%
DPG 5.0質量%
PEG-32、PEG-6 5.0質量%
ココイルグルタミン酸Na 2.5質量%
フェノキシエタノール 0.1質量%
メントール 0.05質量%
香料 0.05質量%
水 残部
合計 100.0質量%
(噴射剤)
LPG 100.0質量%
原液:噴射剤=96:4(質量比)。
[Prescription example 1]
(undiluted solution)
PEG-20 glyceryl triisostearate 0.5% by mass
Fluorosilicic acid (Na/Mg) 0.3% by mass
Xanthan gum 0.1% by mass
Polyglyceryl myristate-10 3.0% by mass
Ceteth-20 1.5% by mass
Concentrated glycerin 10.0% by mass
DPG 5.0% by mass
PEG-32, PEG-6 5.0% by mass
Sodium cocoyl glutamate 2.5% by mass
Phenoxyethanol 0.1% by mass
Menthol 0.05% by mass
Fragrance 0.05% by mass
water remainder
Total 100.0% by mass
(propellant)
LPG 100.0% by mass
Stock solution: propellant = 96:4 (mass ratio).
本発明のフォーム状皮膚洗浄料は、顔、手、身体、頭皮や毛髪用の洗浄料等に使用することができる。 The foamed skin cleanser of the present invention can be used as a cleanser for the face, hands, body, scalp, hair, and the like.
Claims (3)
成分Aの含有量が0.3~10.0質量%であり、成分Bの含有量が0.05~1.5質量%であり、成分Cの含有量が0.03~0.4質量%である、フォーム状皮膚洗浄料;
成分A:ポリオキシエチレングリセリン脂肪酸エステルであり、HLBが4~10であるノニオン界面活性剤
成分B:粘土鉱物
成分C:グルコース、ガラクトース、マンノース、アラビノース、およびキシロースからなる群より選択される単糖類の1種又は2種以上で構成されてなる多糖類および/またはメチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、およびヒドロキシプロピルメチルセルロースからなる群より選択されるノニオン性セルロース系増粘剤。 A foam skin cleansing agent in which a stock solution and a propellant containing a liquefied gas are filled in an aerosol container, the stock solution containing the following components A to C,
The content of component A is 0.3 to 10.0% by mass, the content of component B is 0.05 to 1.5% by mass, and the content of component C is 0.03 to 0.4% by mass. %, foam skin cleanser;
Component A : A nonionic surfactant that is a polyoxyethylene glycerin fatty acid ester and has an HLB of 4 to 10. Component B: Clay mineral. Component C: A monomer selected from the group consisting of glucose, galactose, mannose, arabinose, and xylose. A nonionic cellulose thickener selected from the group consisting of polysaccharides and/or methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, and hydroxypropylmethylcellulose .
前記原液/前記噴射剤の比率が83/17~98/2である、請求項1に記載のフォーム状皮膚洗浄料;
成分D:炭素数12~22の高級脂肪酸および/またはその塩
成分E:HLBが11~17であるノニオン界面活性剤
成分F:水
成分G:多価アルコール
成分H:ラウリルアルコール、ミリスチルアルコール、セチルアルコール(セタノール)、ステアリルアルコール、セテアリルアルコール、イソステアリルアルコール、ヘキシルデカノール、2-オクチルドデカノール、オレイルアルコール、デシルテトラデカノール、およびベヘニルアルコールからなる群から選ばれる、高級アルコール。 The stock solution further contains the following components D to H,
The foam skin cleanser according to claim 1, wherein the ratio of the stock solution/the propellant is from 83/17 to 98/2;
Component D: Higher fatty acid having 12 to 22 carbon atoms and/or its salt Component E: Nonionic surfactant with HLB of 11 to 17 Component F: Water Component G: Polyhydric alcohol Component H: Lauryl alcohol, myristyl alcohol, cetyl A higher alcohol selected from the group consisting of alcohol (cetanol), stearyl alcohol, cetearyl alcohol, isostearyl alcohol, hexyldecanol, 2-octyldodecanol, oleyl alcohol, decyltetradecanol, and behenyl alcohol.
The content of the component D is 0.3 to 5.0% by mass, the content of the component E is 1.0 to 10.0% by mass, and the content of the component G is 5. The foam skin cleanser according to claim 2, wherein the content of component H is 0 to 30.0% by mass and the content of component H is 0.05 to 1.0% by mass.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020051163A JP7427486B2 (en) | 2020-03-23 | 2020-03-23 | foam skin cleanser |
KR1020210018300A KR20210118736A (en) | 2020-03-23 | 2021-02-09 | Foamed skin cleanser |
CN202110195533.XA CN113425607A (en) | 2020-03-23 | 2021-02-19 | Foam-like skin cleanser |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020051163A JP7427486B2 (en) | 2020-03-23 | 2020-03-23 | foam skin cleanser |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021147372A JP2021147372A (en) | 2021-09-27 |
JP7427486B2 true JP7427486B2 (en) | 2024-02-05 |
Family
ID=77752854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020051163A Active JP7427486B2 (en) | 2020-03-23 | 2020-03-23 | foam skin cleanser |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP7427486B2 (en) |
KR (1) | KR20210118736A (en) |
CN (1) | CN113425607A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012240985A (en) | 2011-05-23 | 2012-12-10 | Kao Corp | Aerosol type skin cleanser |
WO2018221420A1 (en) | 2017-05-30 | 2018-12-06 | 株式会社マンダム | Foamed skin cleanser |
JP2019059720A (en) | 2017-09-25 | 2019-04-18 | 株式会社マンダム | Foamy skin cleanser |
JP2019059721A (en) | 2017-09-25 | 2019-04-18 | 株式会社マンダム | Foamy skin cleanser |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3518116B2 (en) | 1995-11-17 | 2004-04-12 | 花王株式会社 | Aerosol composition |
JP2003252725A (en) | 2002-02-28 | 2003-09-10 | Daizo:Kk | Foamable aerosol composition |
JP6369923B2 (en) * | 2015-03-30 | 2018-08-08 | 株式会社マンダム | Foam cosmetic |
JP6645814B2 (en) | 2015-11-24 | 2020-02-14 | 株式会社マンダム | Foam skin cleanser |
CN110612094A (en) * | 2017-09-25 | 2019-12-24 | 株式会社漫丹 | Foam-like skin cleaning material |
EP3697375B1 (en) * | 2017-10-20 | 2021-12-01 | The Procter & Gamble Company | Aerosol foam skin cleanser |
-
2020
- 2020-03-23 JP JP2020051163A patent/JP7427486B2/en active Active
-
2021
- 2021-02-09 KR KR1020210018300A patent/KR20210118736A/en not_active Application Discontinuation
- 2021-02-19 CN CN202110195533.XA patent/CN113425607A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012240985A (en) | 2011-05-23 | 2012-12-10 | Kao Corp | Aerosol type skin cleanser |
WO2018221420A1 (en) | 2017-05-30 | 2018-12-06 | 株式会社マンダム | Foamed skin cleanser |
JP2019059720A (en) | 2017-09-25 | 2019-04-18 | 株式会社マンダム | Foamy skin cleanser |
JP2019059721A (en) | 2017-09-25 | 2019-04-18 | 株式会社マンダム | Foamy skin cleanser |
Non-Patent Citations (1)
Title |
---|
Bubble Rich Cleansing Face Wash, MINTEL GNPD [ONLINE], 2019.01,[検索日 2023.07.14],インターネット:<URL:https://www.gnpd.com/sinatra>(Database accession no.6239481) |
Also Published As
Publication number | Publication date |
---|---|
KR20210118736A (en) | 2021-10-01 |
JP2021147372A (en) | 2021-09-27 |
CN113425607A (en) | 2021-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011129034A1 (en) | Concentrated liquid detergent composition and process for production thereof | |
JP5591436B2 (en) | Low temperature stable cream detergent composition | |
JP3922299B2 (en) | Thickening composition | |
JP6862069B2 (en) | Foam skin cleanser | |
JP6795297B2 (en) | Foam skin cleanser | |
JP6645814B2 (en) | Foam skin cleanser | |
JP2014218465A (en) | Composition for cleansing agents | |
WO2019059392A1 (en) | Foamy skin cleanser | |
JP7121617B2 (en) | foam skin cleanser | |
JP7121618B2 (en) | foam skin cleanser | |
JP7427486B2 (en) | foam skin cleanser | |
JP4733375B2 (en) | Foam cosmetic | |
JP4393937B2 (en) | Facial wash | |
JP7121476B2 (en) | foam skin cleanser | |
JP7424883B2 (en) | aqueous composition | |
JP4491279B2 (en) | Aerosol cosmetics | |
JP7312033B2 (en) | Aerosol composition | |
JP2005325038A (en) | Foam aerosol | |
KR102529753B1 (en) | Skin cleanser composition | |
JP7356155B2 (en) | Foamy aerosol warming skin cleansing composition | |
JP2024060928A (en) | Powder-containing skin cleansers and foam-type skin cleansers | |
JP2023130684A (en) | Aerosol products and post-foaming aerosol compositions | |
JP2005068034A (en) | Cleansing foam | |
JP2024051202A (en) | Aerosol compositions and aerosol products | |
JP2021080205A (en) | Scrub agent-containing skin detergent composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220908 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230718 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230808 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231002 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231227 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240123 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240124 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7427486 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |